CIK: 1111363 - Address: 111 W. 57Th Street, Suite 1100, New York, NY 10019
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret118353-10-6-21-5
P%wins88886313502554

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/12/09 16:43
11/12/09
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP104.5812640D-5572-31-25-76-449-2-294
8/15/08 16:42
8/15/08
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP127.5012438D-26-333-10271973741-43-49-11
3/24/08 17:56
3/24/08
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP56.7111236D-55-50-39-25-9-7674519-720-49
12/18/07 16:22
12/17/07
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP108.4911435D-44-42-30-20-21-13-10-6111-5-26-22-49
5/23/07 14:29
5/22/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM.d525.190106027D
5/23/07 14:29
5/22/07
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDS.d-37737.660-10-2727D
5/17/07 15:52
5/16/07
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP711.5031234D88-15-1-13-15-16-14101-9-14-32
3/23/07 15:53
3/23/07
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP912.6831234D6-10-1-736954612-7-16-45
10/20/06 11:03
10/18/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM.d686.750106027D
8/31/06 11:33
8/30/06
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP611.1921234D26-1-19014151419469290-8
8/21/06 16:54
8/17/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM.d336.50052327D
8/21/06 16:54
8/17/06
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDS.d-18336.500-5-1627D
5/11/06 17:19
5/11/06
TINYHarris & Harris Group Inc /ny/NYFinancInvestInvestorsBrowne G MorganNYDP811.5321233-2-5-8-172319
6/3/04 17:29
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM.d656.500107224D
6/3/04 17:29
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDS.d-81381.270-10-3024D
3/5/04 11:19
3/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM.d939.250107823D
3/5/04 11:19
3/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDS.d-60040.000-15-4023D
1/6/04 09:26
1/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDM469.25052228D
1/6/04 09:26
1/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticBrowne G MorganNYDS-16532.950-5-1528D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact